Key facts
- Notable investors include Neuroceuticals, RMD Partners.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for ACI Research
- ·The full record, as it builds
Funding rounds
No funding rounds for ACI Research are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ACI Research
Provider of research and analysis services intended to provide analysis solutions centered on advanced analysis technology in analytical chemistry. The company's services include chemical analysis of components, analysis consulting, contract analysis, screening of unknown compounds, enabling clients to get a wide range of research and analysis services in analytical chemistry.
- Sector
- Business Products and Services (B2B)
- HQ
- Onna, Japan
- Founded
- 2022
- Website
- acir.co.jp/
- Ownership
- Privately Held (backing)
ACI Research doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ACI Research shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ACI Research in its N-PORT filings yet. We sweep new filings monthly.